ArticleCJC open2024
Monitoring Cardiovascular Disease in Métis Citizens Across Ontario, 2012-2020.
Article in CJC open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global landscape of kidney health across Indigenous populations.Nature reviews. Nephrology · 2026Review
- Sex as a predictor and moderator of psychosocial determinants of cardiometabolic risks for Métis People in Canada.Frontiers in stroke · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Population-based analyses of Métis-specific health outcomes in Canada are limited. This study aimed to address this gap and examine cardiovascular disease outcomes in citizens of the Métis Nation of Ontario (MNO) over a 9-year period. Methods: Under a data governance and sharing agreement between the MNO and ICES, registered MNO citizens aged ≥ 20 years were linked to administrative health data in Ontario. Existing algorithms were used to determine the burden of heart failure and hypertension. In the most recent year, prevalence rates were compared for income quintiles, age, and sex. Results: Age-adjusted prevalence rates of hypertension decreased, and age-adjusted prevalence rates of heart failure increased in MNO citizens from 2012 to 2020. A larger decrease in prevalence of hypertension was observed for female citizens, by 12% from 28.9 per 100 (confidence interval [CI]: 27.6-30.2) in 2012 to 25.4 per 100 (CI: 24.5-26.3) in 2020. As for heart failure, the age-adjusted prevalence rates for male citizens had the largest increase, by 47% from 2.6 per 100 (CI: 2.1-3.1) in 2012 to 3.8 per 100 (CI: 3.3-4.2) in 2020. Hypertension and heart failure were more prevalent in male citizens, those of advanced age, and those living in areas within the lowest income quintile. Conclusions: This study is the first in nearly 10 years to investigate trends in cardiovascular outcomes among MNO citizens. Understanding this burden is critical to the MNO's ability to guide program and policy planning, as well as to advocate within and beyond the health system for Métis-specific needs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.